To assess whether the ICOS agonist-mediated reduction in CD8+ T effector cells would result in impaired IAV-specific cytotoxicity, in vivo CTL assays were performed based on the adoptive transfer of IAV nucleoprotein (NP) peptide loaded splenocytes into ICOS agonist treated and control mice on day 9 post infection. Here, CD8A is linked to infection.